BJOG: An International Journal of Obstetrics & Gynaecology

Volume 120, Issue 13 p. 1661-1667

Original Article

Maternal and health care determinants of preconceptional use of folic acid supplementation in France: results from the 2010 National Perinatal Survey

J Tort,

J Tort

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

N Lelong,

N Lelong

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

C Prunet,

C Prunet

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

B Khoshnood,

B Khoshnood

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

B Blondel,

Corresponding Author

B Blondel

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Correspondence: Dr B Blondel, INSERM U 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Maternité de Port Royal, 53 avenue de l'Observatoire, 75014 Paris, France. Email [email protected]Search for more papers by this author

J Tort,

J Tort

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

N Lelong,

N Lelong

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

C Prunet,

C Prunet

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

B Khoshnood,

B Khoshnood

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

Search for more papers by this author

B Blondel,

Corresponding Author

B Blondel

INSERM UMRS 953, Epidemiological Research Unit on Perinatal and Women's and Children's Health, Paris, France

UPMC University, Paris, France

First published: 10 September 2013

https://doi.org/10.1111/1471-0528.12414

Citations: 39

Share a link

Email
Facebook
Twitter
LinkedIn
Reddit
Wechat

Abstract

Objectives

To estimate the national prevalence and analyse the factors associated with preconceptional folic acid supplementation, including maternal sociodemographic characteristics, region of residence, birth control use and chronic diseases requiring medical care before conception.

Design

Cross-sectional population-based study.

Setting

All maternity units in France.

Population

A nationally representative sample of women giving birth in 2010 (n = 12,646).

Methods

Data came from mothers' interviews 2–3 days after delivery. Statistical analyses included multivariable logistic regressions.

Main outcome measure

Folic acid supplementation starting at least 1 month before conception.

Results

14.8% (95% confidence interval [95% CI] 14.2–15.4) of women used folic acid before pregnancy; this percentage varied from 10.4% to 18.7% across regions. Supplementation was more frequent in primiparae, French citizens, women with higher educational levels and those needing medical monitoring or treatment before conception. Women who stopped contraception to become pregnant (75% of our population) used folic acid more often (intrauterine device or implant: 19%, pill: 17%, other methods which did not need medical monitoring: 17%) than other women (7%). The adjusted odds ratios were 3.3 (95% CI 2.6–4.3) for intrauterine device and implant, 2.2 (95% CI 1.8–2.6) for pill and 1.9 (95% CI 1.5–2.4) for other methods, compared with women who did not use birth control.

Conclusion

The absence of preconceptional folic acid supplementation for most women, even those needing consultations with healthcare professionals before pregnancy, shows that campaigns to promote folic acid supplementation should address not only women but also healthcare professionals involved in birth control and obstetric care before pregnancy.

References

1Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet 2004; 364: 1885–95.
10.1016/S0140-6736(04)17445-X
PubMedWeb of Science®Google Scholar
2Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 2008; 115: 689–96.
10.1111/j.1471-0528.2008.01700.x
CASPubMedWeb of Science®Google Scholar
3De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; 10: CD007950.
PubMedWeb of Science®Google Scholar
4 EUROCAT Folic Acid Working group. Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. 2009 [www.eurocat.ulster.ac.uk]. Accessed 1 March 2013.
Google Scholar
5Busby A, Abramsky L, Dolk H, Armstrong B. Preventing neural tube defects in Europe: population based study. BMJ 2005; 330: 574–5.
10.1136/bmj.330.7491.574
PubMedWeb of Science®Google Scholar
6Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF. Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification? Public Health Nutr 2004; 7: 843–50.
10.1079/PHN2004630
PubMedWeb of Science®Google Scholar
7Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, et al. Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian mother and child cohort study. Am J Clin Nutr 2006; 84: 1134–41.
10.1093/ajcn/84.5.1134
CASPubMedWeb of Science®Google Scholar
8McNally S, Bourke A. Periconceptional folic acid supplementation in a nationally representative sample of mothers. Ir Med J 2012; 105: 236–8.
CASPubMedGoogle Scholar
9Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004; 111: 399–408.
10.1111/j.1471-0528.2004.00115.x
CASPubMedWeb of Science®Google Scholar
10Cueto HT, Riis AH, Hatch EE, Wise LA, Rothman KJ, Mikkelsen EM. Predictors of preconceptional folic acid or multivitamin supplement use: a cross-sectional study of Danish pregnancy planners. Clin Epidemiol 2012; 4: 259–65.
10.2147/CLEP.S35463
PubMedGoogle Scholar
11Blondel B, Lelong N, Kermarrec M, Goffinet F. Trends in perinatal health in France from 1995 to 2010. results from the French national perinatal surveys. J Gynecol Obstet Biol Reprod 2012; 41(4): e1–15.
10.1016/j.jgyn.2012.04.014
CASPubMedGoogle Scholar
12Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996; 275: 1093–6.
10.1001/jama.1996.03530380035028
CASPubMedWeb of Science®Google Scholar
13Zestra-Van der Woude PA, De Walle HEK, De jong-Van den Berg LTW. Periconceptional folic acid use: still room to improve. Birth Defects Res Part A Clin Mol Teratol 2012; 94: 96–101.
10.1002/bdra.22882
CASWeb of Science®Google Scholar
14Timmermans S, Jaddoe VWV, Mackenbach JP, Hofman A, Steegers-Theunissen RPM, Steegers EAP. Determinants of folic acid use in early pregnancy in a multi-ethnic urban population in the Netherlands: the generation R study. Prev Med 2008; 47(4): 427–32.
10.1016/j.ypmed.2008.06.014
CASPubMedWeb of Science®Google Scholar
15Coll O, Pisa S, Palacio M, Quintó L, Cararach V. Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area. Eur J Obstet Gynecol Reprod Biol 2004; 115: 173–7.
10.1016/j.ejogrb.2003.12.009
CASPubMedWeb of Science®Google Scholar
16Braekke K, Staff AC. Periconceptional use of folic acid supplements in Oslo. Acta Obstet Gynecol Scand 2003; 82: 620–7.
10.1034/j.1600-0412.2003.00180.x
CASPubMedWeb of Science®Google Scholar
17De Jong-Van den Berg LTW, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol 2005; 192: 121–8.
10.1016/j.ajog.2004.05.085
PubMedWeb of Science®Google Scholar
18De Walle HEK, De Jong-van den Berg LTW. Ten years after the Dutch public health campaign on folic acid: the continuing challenge. Eur J Clin Pharmacoli 2008; 64: 539–43.
10.1007/s00228-007-0446-6
PubMedWeb of Science®Google Scholar
19Zeng Z, Yuan P, Wang Y, Ma X, Zhu J. Folic acid awareness and intake among women in areas with high prevalence of neural tube defects in China: a cross-sectional study. Public Health Nutr 2011; 14: 1142–7.
10.1017/S1368980011000097
PubMedWeb of Science®Google Scholar
20Baraka MA, Steurbaut S, Leemans L, Foulon W, Laubach M, Coomans D, et al. Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional study. J Perinat Med 2011; 39: 685–92.
10.1515/jpm.2011.085
PubMedWeb of Science®Google Scholar
21Mallard SR, Houghton LA. Folate knowledge and consumer behaviour among pregnant New Zealand women prior to the potential introduction of mandatory fortification. Asia Pac J Clin Nutr 2012; 21: 440–9.
CASPubMedWeb of Science®Google Scholar
22Van Eijsden M, Van der Wal MF, Bonsel GJ. Folic acid knowledge and use in a multi-ethnic pregnancy cohort: the role of language proficency. BJOG 2006; 113: 1446–51.
10.1111/j.1471-0528.2006.01096.x
Web of Science®Google Scholar
23Riskin-Mashiah S, Auslender R. Periconceptional folic acid and teratogenic drug use in women undergoing fertility treatments. J Matern Fetal Neonatal Med 2012; 25: 1899–903.
10.3109/14767058.2012.668586
CASWeb of Science®Google Scholar
24Forges T, Monnier-Barbarino P, Alberto JM, Guéant-Rodriguez RM, Daval JL, Guéant JL. Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 2007; 13: 225–38.
10.1093/humupd/dml063
CASPubMedWeb of Science®Google Scholar
25De Jong-van den Berg LTW, De Walle HEK, Van der Pal-de Bruin KM, Buitendijk SE, Cornel MC. Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from, to 1995. Eur J Clin Pharmacol 1994; 1998(54): 329–31.
Google Scholar
26Amitai Y, Fisher N, Meiraz H, Baram N, Tounis M, Leventhal A. Preconceptional folic acid utilization in Israel: five years after the guidelines. Prev Med 2008; 46: 166–9.
10.1016/j.ypmed.2007.09.005
PubMedWeb of Science®Google Scholar
27Stockley L, Lund V. Use of folic acid supplements, particularly by low-income and young women: a series of systematic reviews to inform public health policy in the UK. Public Health Nutr 2008; 11: 807–21.
10.1017/S1368980008002346
PubMedWeb of Science®Google Scholar
28Dott M, Rasmussen SA, Hogue CJ, Reefhuis J. Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, national birth defects prevention Study, 1997–2002. Matern Child Health J 2010; 14: 373–81.
10.1007/s10995-009-0458-1
PubMedWeb of Science®Google Scholar
29Tydén T, Stern J, Nydahl M, Berglund A, Larsson M, Rosenblad A, et al. Pregnancy planning in Sweden—a pilot study among 270 women attending antenatal clinics. Acta Obstet Gynecol Scand 2011; 90: 408–12.
10.1111/j.1600-0412.2010.01055.x
PubMedWeb of Science®Google Scholar
30De Weerd S, Thomas CMG, Cikot RJLM, Steegers-Theunissen RPM, De Boo TM, Steegers EAP. Preconception counseling improves folate status of women planning pregnancy. Obstet Gynecol 2002; 99: 45–50.
10.1016/S0029-7844(01)01573-3
PubMedWeb of Science®Google Scholar
31Holzgreve W, Pietrzik K, Koletzko B, Eckmann-Scholz C. Adding folate to the contraceptive pill: a new concept for the prevention of neural tube defects. J Matern Fetal Neonatal Med 2012; 25: 1529–36.
10.3109/14767058.2011.648672
CASWeb of Science®Google Scholar
32McDonnell R, Johnson Z, Doyle A, Sayers G. Determinants of folic acid knowledge and use among antenatal women. J Public Health Med 1999; 21: 145–9.
10.1093/pubmed/21.2.145
CASPubMedWeb of Science®Google Scholar
33Crider KS, Bailey LB, Berry RJ. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients 2011; 3: 370–84.
10.3390/nu3030370
PubMedWeb of Science®Google Scholar
34Cuskelly GJ, Mooney KM, Young IS. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 2007; 66: 548–58.
10.1017/S0029665107005873
CASPubMedWeb of Science®Google Scholar
35Kim Y-I. Folic acid fortification and supplementation—good for some but not so good for others. Nutr Rev 2007; 65: 504–11.
10.1111/j.1753-4887.2007.tb00275.x
CASPubMedWeb of Science®Google Scholar

Citing Literature

Volume120, Issue13

December 2013

Pages 1661-1667

Maternal and health care determinants of preconceptional use of folic acid supplementation in France: results from the 2010 National Perinatal Survey

Abstract

Objectives

Design

Setting

Population

Methods

Main outcome measure

Results

Conclusion

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Maternal and health care determinants of preconceptional use of folic acid supplementation in France: results from the 2010 National Perinatal Survey

Abstract

Objectives

Design

Setting

Population

Methods

Main outcome measure

Results

Conclusion

References

Citing Literature

References

Related

Information